1. The Antibiotic Trimethoprim Displays Strong Mutagenic Synergy with 2-Aminopurine.
- Author
-
D'Souza S, Miller JE, Ahn J, Subandi R, Lozano D, Ramirez J, Goff M, Davidian C, and Miller JH
- Subjects
- DNA-Directed RNA Polymerases drug effects, Drug Synergism, Escherichia coli drug effects, Escherichia coli Proteins drug effects, 2-Aminopurine pharmacology, Anti-Bacterial Agents pharmacology, Escherichia coli genetics, Mutagenesis drug effects, Mutagens pharmacology, Trimethoprim pharmacology
- Abstract
We show that trimethoprim (TMP), an antibiotic in current use, displays a strong synergistic effect on mutagenesis in Escherichia coli when paired with the base analog 2-aminopurine (2AP), resulting in a 35-fold increase in mutation frequencies in the rpoB -Rif
r system. Combination therapies are often employed both as antibiotic treatments and in cancer chemotherapy. However, mutagenic effects of these combinations are rarely examined. An analysis of the mutational spectra of TMP, 2AP, and their combination indicates that together they trigger a response via an alteration in deoxynucleoside triphosphate (dNTP) ratios that neither compound alone can trigger. A similar, although less strong, response is seen with the frameshift mutagen ICR191 and 2AP. These results underscore the need for testing the effects on mutagenesis of combinations of antibiotics and chemotherapeutics., (Copyright © 2019 American Society for Microbiology.)- Published
- 2019
- Full Text
- View/download PDF